APO Research
Talk to an analyst

APO RESEARCH · REPORT

Integrated Precision Diagnosis and Treatment Solution

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Integrated Precision Diagnosis and Treatment Solution Market Outlook and Growth Opportunities 2026

1 January 2026194 pages

Choose your research edition.

Industry ResearchIntegrated Precision Diagnosis and Treatment Solution Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Integrated Precision Diagnosis and Treatment Solution Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Integrated Precision Diagnosis and Treatment Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Integrated Precision Diagnosis and Treatment Solution Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Integrated Precision Diagnosis and Treatment Solution Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Integrated Precision Diagnosis and Treatment Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Integrated Precision Diagnosis and Treatment Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Integrated Precision Diagnosis and Treatment Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Integrated Precision Diagnosis and Treatment Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Integrated Precision Diagnosis and Treatment Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Integrated Precision Diagnosis and Treatment Solution market include Illumina, QIAGEN, Caris Life Sciences, Foundation Medicine, Guardant Health, NeoGenomics, Myriad Genetics, Thermo Fisher Scientific and Roche Holding AG, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Integrated Precision Diagnosis and Treatment Solution market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Integrated Precision Diagnosis and Treatment Solution and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Integrated Precision Diagnosis and Treatment Solution revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Integrated Precision Diagnosis and Treatment Solution market.

Integrated Precision Diagnosis and Treatment Solution Segment by Company

Illumina

QIAGEN

Caris Life Sciences

Foundation Medicine

Guardant Health

NeoGenomics

Myriad Genetics

Thermo Fisher Scientific

Roche Holding AG

Abbott Laboratories

GE HealthCare

Tempus Labs

Personalis

Genome Medical

Endeavor Biomedicines

Integrated Precision Diagnosis and Treatment Solution Segment by Type

Genomics

Proteomics

Metabolomics

Radiomics

Integrated Precision Diagnosis and Treatment Solution Segment by Application

Medical Institutions

Research and Academic Institutions

Integrated Precision Diagnosis and Treatment Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Integrated Precision Diagnosis and Treatment Solution status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Integrated Precision Diagnosis and Treatment Solution key companies, revenue, market share, and recent developments.

3. To split the Integrated Precision Diagnosis and Treatment Solution breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Integrated Precision Diagnosis and Treatment Solution market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Integrated Precision Diagnosis and Treatment Solution significant trends, drivers, influence factors in global and regions.

6. To analyze Integrated Precision Diagnosis and Treatment Solution competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Integrated Precision Diagnosis and Treatment Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Integrated Precision Diagnosis and Treatment Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Integrated Precision Diagnosis and Treatment Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Integrated Precision Diagnosis and Treatment Solution industry.

Chapter 3: Detailed analysis of Integrated Precision Diagnosis and Treatment Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Integrated Precision Diagnosis and Treatment Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Integrated Precision Diagnosis and Treatment Solution in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Integrated Precision Diagnosis and Treatment Solution Industry Trends Table 2. Integrated Precision Diagnosis and Treatment Solution Industry Drivers Table 3. Integrated Precision Diagnosis and Treatment Solution Industry Opportunities and Challenges Table 4. Integrated Precision Diagnosis and Treatment Solution Industry Restraints Table 5. Global Integrated Precision Diagnosis and Treatment Solution Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Integrated Precision Diagnosis and Treatment Solution Revenue Share by Company (2021-2026) Table 7. Global Integrated Precision Diagnosis and Treatment Solution Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Integrated Precision Diagnosis and Treatment Solution Key Company Manufacturing Base & Headquarters Table 9. Global Integrated Precision Diagnosis and Treatment Solution Company, Product Type & Application Table 10. Global Integrated Precision Diagnosis and Treatment Solution Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Integrated Precision Diagnosis and Treatment Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Genomics Table 15. Significant Companies of Proteomics Table 16. Significant Companies of Metabolomics Table 17. Significant Companies of Radiomics Table 18. Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type (2021-2026) Table 22. Global Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Medical Institutions Table 24. Significant Companies of Research and Academic Institutions Table 25. Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application (2021-2026) Table 29. Global Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application (2027-2032) Table 30. Global Integrated Precision Diagnosis and Treatment Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Region (2021-2026) Table 33. Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Region (2027-2032) Table 35. Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Integrated Precision Diagnosis and Treatment Solution Sales Value Market Share by Country (2021-2026) Table 38. Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Integrated Precision Diagnosis and Treatment Solution Sales Value Market Share by Country (2027-2032) Table 40. Illumina Company Information Table 41. Illumina Business Overview Table 42. Illumina Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Illumina Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 44. Illumina Recent Development Table 45. QIAGEN Company Information Table 46. QIAGEN Business Overview Table 47. QIAGEN Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. QIAGEN Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 49. QIAGEN Recent Development Table 50. Caris Life Sciences Company Information Table 51. Caris Life Sciences Business Overview Table 52. Caris Life Sciences Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Caris Life Sciences Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 54. Caris Life Sciences Recent Development Table 55. Foundation Medicine Company Information Table 56. Foundation Medicine Business Overview Table 57. Foundation Medicine Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Foundation Medicine Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 59. Foundation Medicine Recent Development Table 60. Guardant Health Company Information Table 61. Guardant Health Business Overview Table 62. Guardant Health Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Guardant Health Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 64. Guardant Health Recent Development Table 65. NeoGenomics Company Information Table 66. NeoGenomics Business Overview Table 67. NeoGenomics Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. NeoGenomics Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 69. NeoGenomics Recent Development Table 70. Myriad Genetics Company Information Table 71. Myriad Genetics Business Overview Table 72. Myriad Genetics Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Myriad Genetics Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 74. Myriad Genetics Recent Development Table 75. Thermo Fisher Scientific Company Information Table 76. Thermo Fisher Scientific Business Overview Table 77. Thermo Fisher Scientific Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Thermo Fisher Scientific Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 79. Thermo Fisher Scientific Recent Development Table 80. Roche Holding AG Company Information Table 81. Roche Holding AG Business Overview Table 82. Roche Holding AG Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Roche Holding AG Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 84. Roche Holding AG Recent Development Table 85. Abbott Laboratories Company Information Table 86. Abbott Laboratories Business Overview Table 87. Abbott Laboratories Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Abbott Laboratories Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 89. Abbott Laboratories Recent Development Table 90. GE HealthCare Company Information Table 91. GE HealthCare Business Overview Table 92. GE HealthCare Integrated Precision Diagnosis and Treatment Solution Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. GE HealthCare Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 94. GE HealthCare Recent Development Table 95. Tempus Labs Company Information Table 96. Tempus Labs Business Overview Table 97. Tempus Labs Integrated Precision Diagnosis and Treatment Solution Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Tempus Labs Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 99. Tempus Labs Recent Development Table 100. Personalis Company Information Table 101. Personalis Business Overview Table 102. Personalis Integrated Precision Diagnosis and Treatment Solution Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Personalis Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 104. Personalis Recent Development Table 105. Genome Medical Company Information Table 106. Genome Medical Business Overview Table 107. Genome Medical Integrated Precision Diagnosis and Treatment Solution Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Genome Medical Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 109. Genome Medical Recent Development Table 110. Endeavor Biomedicines Company Information Table 111. Endeavor Biomedicines Business Overview Table 112. Endeavor Biomedicines Integrated Precision Diagnosis and Treatment Solution Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Endeavor Biomedicines Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 114. Endeavor Biomedicines Recent Development Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Integrated Precision Diagnosis and Treatment Solution Product Image Figure 2. Global Integrated Precision Diagnosis and Treatment Solution Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Integrated Precision Diagnosis and Treatment Solution Market Size (2021-2032) & (US$ Million) Figure 4. Global Integrated Precision Diagnosis and Treatment Solution Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Genomics Image Figure 8. Proteomics Image Figure 9. Metabolomics Image Figure 10. Radiomics Image Figure 11. Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Integrated Precision Diagnosis and Treatment Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type (2021-2032) Figure 14. Medical Institutions Image Figure 15. Research and Academic Institutions Image Figure 16. Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Integrated Precision Diagnosis and Treatment Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application (2021-2032) Figure 19. Global Integrated Precision Diagnosis and Treatment Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Integrated Precision Diagnosis and Treatment Solution Sales Value (2021-2032) & (US$ Million) Figure 22. North America Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Integrated Precision Diagnosis and Treatment Solution Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Integrated Precision Diagnosis and Treatment Solution Sales Value (2021-2032) & (US$ Million) Figure 28. South America Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Genomics
  • Proteomics
  • Metabolomics
  • Radiomics
Applications
  • Medical Institutions
  • Research and Academic Institutions
Companies covered
  • Illumina
  • QIAGEN
  • Caris Life Sciences
  • Foundation Medicine
  • Guardant Health
  • NeoGenomics
  • Myriad Genetics
  • Thermo Fisher Scientific
  • Roche Holding AG
  • Abbott Laboratories
  • GE HealthCare
  • Tempus Labs
  • Personalis
  • Genome Medical
  • Endeavor Biomedicines

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Integrated Precision Diagnosis and Treatment Solution Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Integrated Precision Diagnosis and Treatment Solution Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Integrated Precision Diagnosis and Treatment Solution Market Dynamics
  1. 2.1 Integrated Precision Diagnosis and Treatment Solution Industry Trends
  2. 2.2 Integrated Precision Diagnosis and Treatment Solution Industry Drivers
  3. 2.3 Integrated Precision Diagnosis and Treatment Solution Industry Opportunities and Challenges
  4. 2.4 Integrated Precision Diagnosis and Treatment Solution Industry Restraints
3 Integrated Precision Diagnosis and Treatment Solution Market by Company
  1. 3.1 Global Integrated Precision Diagnosis and Treatment Solution Company Revenue Ranking in 2025
  2. 3.2 Global Integrated Precision Diagnosis and Treatment Solution Revenue by Company (2021-2026)
  3. 3.3 Global Integrated Precision Diagnosis and Treatment Solution Company Ranking (2024-2026)
  4. 3.4 Global Integrated Precision Diagnosis and Treatment Solution Company Manufacturing Base and Headquarters
  5. 3.5 Global Integrated Precision Diagnosis and Treatment Solution Company Product Type and Application
  6. 3.6 Global Integrated Precision Diagnosis and Treatment Solution Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Integrated Precision Diagnosis and Treatment Solution Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Integrated Precision Diagnosis and Treatment Solution Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Integrated Precision Diagnosis and Treatment Solution Market by Type
  1. 4.1 Integrated Precision Diagnosis and Treatment Solution Type Introduction
  2. 4.1.1 Genomics
  3. 4.1.2 Proteomics
  4. 4.1.3 Metabolomics
  5. 4.1.4 Radiomics
  6. 4.2 Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Type
  7. 4.2.1 Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Type (2021-2032)
  9. 4.2.3 Global Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type (2021-2032)
5 Integrated Precision Diagnosis and Treatment Solution Market by Application
  1. 5.1 Integrated Precision Diagnosis and Treatment Solution Application Introduction
  2. 5.1.1 Medical Institutions
  3. 5.1.2 Research and Academic Institutions
  4. 5.2 Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Application
  5. 5.2.1 Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Application (2021-2032)
  7. 5.2.3 Global Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application (2021-2032)
6 Integrated Precision Diagnosis and Treatment Solution Regional Value Analysis
  1. 6.1 Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Region (2021-2032)
  3. 6.2.1 Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Region: 2021-2026
  4. 6.2.2 Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Integrated Precision Diagnosis and Treatment Solution Sales Value (2021-2032)
  7. 6.3.2 North America Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Integrated Precision Diagnosis and Treatment Solution Sales Value (2021-2032)
  10. 6.4.2 Europe Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Integrated Precision Diagnosis and Treatment Solution Sales Value (2021-2032)
  16. 6.6.2 South America Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Country, 2025 VS 2032
7 Integrated Precision Diagnosis and Treatment Solution Country-level Value Analysis
  1. 7.1 Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Country (2021-2032)
  3. 7.2.1 Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Country (2021-2026)
  4. 7.2.2 Global Integrated Precision Diagnosis and Treatment Solution Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Integrated Precision Diagnosis and Treatment Solution Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Integrated Precision Diagnosis and Treatment Solution Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Illumina
  2. 8.1.1 Illumina Company Information
  3. 8.1.2 Illumina Business Overview
  4. 8.1.3 Illumina Integrated Precision Diagnosis and Treatment Solution Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Illumina Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  6. 8.1.5 Illumina Recent Developments
  7. 8.2 QIAGEN
  8. 8.2.1 QIAGEN Company Information
  9. 8.2.2 QIAGEN Business Overview
  10. 8.2.3 QIAGEN Integrated Precision Diagnosis and Treatment Solution Revenue and Gross Margin (2021-2026)
  11. 8.2.4 QIAGEN Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  12. 8.2.5 QIAGEN Recent Developments
  13. 8.3 Caris Life Sciences
  14. 8.3.1 Caris Life Sciences Company Information
  15. 8.3.2 Caris Life Sciences Business Overview
  16. 8.3.3 Caris Life Sciences Integrated Precision Diagnosis and Treatment Solution Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Caris Life Sciences Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  18. 8.3.5 Caris Life Sciences Recent Developments
  19. 8.4 Foundation Medicine
  20. 8.4.1 Foundation Medicine Company Information
  21. 8.4.2 Foundation Medicine Business Overview
  22. 8.4.3 Foundation Medicine Integrated Precision Diagnosis and Treatment Solution Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Foundation Medicine Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  24. 8.4.5 Foundation Medicine Recent Developments
  25. 8.5 Guardant Health
  26. 8.5.1 Guardant Health Company Information
  27. 8.5.2 Guardant Health Business Overview
  28. 8.5.3 Guardant Health Integrated Precision Diagnosis and Treatment Solution Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Guardant Health Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  30. 8.5.5 Guardant Health Recent Developments
  31. 8.6 NeoGenomics
  32. 8.6.1 NeoGenomics Company Information
  33. 8.6.2 NeoGenomics Business Overview
  34. 8.6.3 NeoGenomics Integrated Precision Diagnosis and Treatment Solution Revenue and Gross Margin (2021-2026)
  35. 8.6.4 NeoGenomics Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  36. 8.6.5 NeoGenomics Recent Developments
  37. 8.7 Myriad Genetics
  38. 8.7.1 Myriad Genetics Company Information
  39. 8.7.2 Myriad Genetics Business Overview
  40. 8.7.3 Myriad Genetics Integrated Precision Diagnosis and Treatment Solution Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Myriad Genetics Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  42. 8.7.5 Myriad Genetics Recent Developments
  43. 8.8 Thermo Fisher Scientific
  44. 8.8.1 Thermo Fisher Scientific Company Information
  45. 8.8.2 Thermo Fisher Scientific Business Overview
  46. 8.8.3 Thermo Fisher Scientific Integrated Precision Diagnosis and Treatment Solution Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Thermo Fisher Scientific Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  48. 8.8.5 Thermo Fisher Scientific Recent Developments
  49. 8.9 Roche Holding AG
  50. 8.9.1 Roche Holding AG Company Information
  51. 8.9.2 Roche Holding AG Business Overview
  52. 8.9.3 Roche Holding AG Integrated Precision Diagnosis and Treatment Solution Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Roche Holding AG Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  54. 8.9.5 Roche Holding AG Recent Developments
  55. 8.10 Abbott Laboratories
  56. 8.10.1 Abbott Laboratories Company Information
  57. 8.10.2 Abbott Laboratories Business Overview
  58. 8.10.3 Abbott Laboratories Integrated Precision Diagnosis and Treatment Solution Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Abbott Laboratories Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  60. 8.10.5 Abbott Laboratories Recent Developments
  61. 8.11 GE HealthCare
  62. 8.11.1 GE HealthCare Company Information
  63. 8.11.2 GE HealthCare Business Overview
  64. 8.11.3 GE HealthCare Integrated Precision Diagnosis and Treatment Solution Revenue and Gross Margin (2021-2026)
  65. 8.11.4 GE HealthCare Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  66. 8.11.5 GE HealthCare Recent Developments
  67. 8.12 Tempus Labs
  68. 8.12.1 Tempus Labs Company Information
  69. 8.12.2 Tempus Labs Business Overview
  70. 8.12.3 Tempus Labs Integrated Precision Diagnosis and Treatment Solution Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Tempus Labs Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  72. 8.12.5 Tempus Labs Recent Developments
  73. 8.13 Personalis
  74. 8.13.1 Personalis Company Information
  75. 8.13.2 Personalis Business Overview
  76. 8.13.3 Personalis Integrated Precision Diagnosis and Treatment Solution Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Personalis Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  78. 8.13.5 Personalis Recent Developments
  79. 8.14 Genome Medical
  80. 8.14.1 Genome Medical Company Information
  81. 8.14.2 Genome Medical Business Overview
  82. 8.14.3 Genome Medical Integrated Precision Diagnosis and Treatment Solution Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Genome Medical Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  84. 8.14.5 Genome Medical Recent Developments
  85. 8.15 Endeavor Biomedicines
  86. 8.15.1 Endeavor Biomedicines Company Information
  87. 8.15.2 Endeavor Biomedicines Business Overview
  88. 8.15.3 Endeavor Biomedicines Integrated Precision Diagnosis and Treatment Solution Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Endeavor Biomedicines Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  90. 8.15.5 Endeavor Biomedicines Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst